An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy

被引:0
|
作者
De Caro, Francesco [1 ,2 ,3 ]
Pecoraro, Nadia [1 ]
Capunzo, Mario [2 ,3 ]
Caruccio, Simona [2 ]
Caggiano, Filippo [3 ]
Cersosimo, Giuseppina [4 ]
Costantino, Maria [2 ,3 ]
Longanella, Walter [3 ]
Malatesta, Francesca [1 ]
Tomeo, Matteo [2 ]
Savarese, Giulia [2 ]
Sinopoli, Pio [2 ]
Vozzella, Emilia Anna [3 ]
Moccia, Giuseppina [1 ]
机构
[1] Univ Salerno, Dept Med & Surg & Dent, Publ Hlth Lab Anal Community Hlth Needs, Baronissi Campus, I-84081 Baronissi, Italy
[2] Univ Salerno, Dept Med Surg & Dent, Baronissi Campus, I-84081 Baronissi, Italy
[3] Hosp San Giovanni Dio & Ruggi Aragona, I-84131 Salerno, Italy
[4] Univ Salerno, Dept Polit & Social Studies, I-84084 Fisciano, Italy
来源
PATHOGENS | 2025年 / 14卷 / 02期
关键词
Herpes Zoster; illness representations; vaccination; hospital vaccination; fragile patients; vaccinal campaigns; vaccine hesitancy; SUBUNIT VACCINE; EFFICACY;
D O I
10.3390/pathogens14020145
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the context of the Italian National Herpes Zoster Vaccine program, an exploratory survey was conducted on a sample of fragile adult patients to investigate the representations of the disease and its prevention to build future local vaccination campaigns. An ad hoc questionnaire was administered to 271 fragile adult patients who had adjuvanted recombinant Herpes Zoster vaccination to detect the following: knowledge and perception of the disease and its risks; information sources and confidence in the information sources used; and perception of the Herpes Zoster vaccination. Fragile adult patients have the representation of Herpes Zoster as a serious disease (86.5%), and they consider themselves informed concerning symptoms and health effects. Women are more fearful of the impact of the disease (Chi-square = 10.03; DF = 3; p-value = 0.018), while those with a higher average age consider themselves less informed (R = -158; p-value = 0.039). The sources of information that contributed to the construction of illness representation are health personnel (73.5%), followed by the web and social web (14.7%), and media such as radio and TV (10.0%). Regarding the vaccine representation, fragile patients are confident about the vaccine and the science behind it and believe everyone should receive it. However, a high percentage (62.9%) fear side effects. Our analysis highlights that vaccination campaigns must be planned based on the target audience, individual and contextual needs, and representations of the disease, particularly when dealing with frail patients, to implement effective preventive interventions.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine
    Heineman, Thomas C.
    Cunningham, Anthony
    Levin, Myron
    CURRENT OPINION IN IMMUNOLOGY, 2019, 59 : 42 - 48
  • [32] Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States
    Lu, Angela
    Sun, Yuwei
    Porco, Travis C.
    Arnold, Benjamin F.
    Acharya, Nisha R.
    OPHTHALMOLOGY, 2021, 128 (12) : 1699 - 1707
  • [33] Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
    Giannelos, Nikolaos
    Ng, Cheryl
    Curran, Desmond
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [34] Time to talk to adults with rheumatic diseases about herpes zoster vaccination
    Pier, Mischa
    Wolbink, Gertjan
    Boekel, Laura
    LANCET RHEUMATOLOGY, 2024, 6 (04) : e247 - e251
  • [35] Herpes zoster: vaccination status and virtuous experiences
    Cocchio, Silvia
    Gallo, Tolinda
    Baldo, Vincenzo
    MINERVA MEDICA, 2020, 111 (01) : 4 - 8
  • [36] Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia
    Singh, Grisuna
    Song, Sejin
    Choi, Eunjoo
    Lee, Pyung-Bok
    Nahm, Francis Sahngun
    KOREAN JOURNAL OF PAIN, 2020, 33 (03) : 201 - 207
  • [37] Herpes Zoster Vaccination Reduces Risk of Dementia
    Lehrer, Steven
    Rheinstein, Peter H.
    IN VIVO, 2021, 35 (06): : 3271 - 3275
  • [38] Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
    de Boer, Pieter T.
    van Lier, Alies
    de Melker, Hester
    van Wijck, Albert J. M.
    Wilschut, Jan C.
    van Hoek, Albert Jan
    Postma, Maarten J.
    BMC MEDICINE, 2018, 16
  • [39] Logistic and organizational barriers to herpes zoster vaccination in europe: A systematic review
    Sorrentino, Michele
    Belpiede, Alessandro
    Fiorilla, Claudio
    Mercogliano, Michelangelo
    Triassi, Maria
    Palladino, Raffale
    VACCINE: X, 2024, 20
  • [40] Herpes zoster vaccination. An update
    Djawad, Khairuddin
    Amin, Safruddin
    Adriani, Anni
    Djamaluddin, Widyawati
    Kadir, Dirmawati
    Muchtar, Sri Vitayani
    PRZEGLAD DERMATOLOGICZNY, 2021, 108 (06): : 517 - 525